BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18075378)

  • 1. Stem cell delivery to the heart: clarifying methodology and mechanism.
    Crisostomo PR; Meldrum DR
    Crit Care Med; 2007 Nov; 35(11):2654-6. PubMed ID: 18075378
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of using autologous mono-nuclears of the bone marrow in treatment of patients with ischemic heart disease].
    Sedov VM; Nemkov AS; Afanas'ev BV; Zverev OG; Nesterko AO; Fregatova LM; Belyĭ SA; Shloĭdo EA; Iudina OV; Ryzhkova DV; Zueva EE; Petrov NV; Stovpiuk OF; Tsurupa SP
    Vestn Khir Im I I Grek; 2006; 165(4):11-4. PubMed ID: 17120413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from the AHA late-breaking trials on cell-based therapies.
    Taylor J
    Eur Heart J; 2013 Apr; 34(14):1016-7. PubMed ID: 23682394
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential hazards and technical considerations associated with myocardial cell transplantation protocols for ischemic myocardial syndrome.
    Ben-Dor I; Fuchs S; Kornowski R
    J Am Coll Cardiol; 2006 Oct; 48(8):1519-26. PubMed ID: 17045883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
    Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
    Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial regeneration by stem cells: still a black box.
    Heilmann C
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):255. PubMed ID: 18455419
    [No Abstract]   [Full Text] [Related]  

  • 7. Current status of cell therapy for systemic arterial hypertension.
    Silva VJ; Machado MP; Voltarelli JC
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1307-11. PubMed ID: 19900013
    [No Abstract]   [Full Text] [Related]  

  • 8. Stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.
    Franz WM; Zaruba M; Theiss H; David R
    Lancet; 2003 Aug; 362(9385):675-6. PubMed ID: 12957085
    [No Abstract]   [Full Text] [Related]  

  • 9. Current status of intramyocardial bone marrow stem cell transplantation.
    Kaminski A; Steinhoff G
    Semin Thorac Cardiovasc Surg; 2008; 20(2):119-25. PubMed ID: 18707644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new bone marrow transplantation method for stem cell disorders.
    Ikehara S
    Ann N Y Acad Sci; 2009 Sep; 1173():774-80. PubMed ID: 19758228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease.
    Shi RZ; Li QP
    Biochem Biophys Res Commun; 2008 Nov; 376(2):247-50. PubMed ID: 18789897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-based therapy for ischemic heart disease: a clinical update.
    Herrmann JL; Abarbanell AM; Weil BR; Wang Y; Wang M; Tan J; Meldrum DR
    Ann Thorac Surg; 2009 Nov; 88(5):1714-22. PubMed ID: 19853156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell therapy for acute myocardial infarction.
    Wollert KC
    Curr Opin Pharmacol; 2008 Apr; 8(2):202-10. PubMed ID: 18243051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation for ischemic myocardial dysfunction.
    Ting AE; Sherman W
    Curr Opin Organ Transplant; 2012 Dec; 17(6):675-80. PubMed ID: 23111647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicardial deposition of endothelial progenitor and mesenchymal stem cells in a coated muscle patch after myocardial infarction in a murine model.
    Derval N; Barandon L; Dufourcq P; Leroux L; Lamazière JM; Daret D; Couffinhal T; Duplàa C
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):248-54. PubMed ID: 18457957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction.
    Mathieu M; Bartunek J; El Oumeiri B; Touihri K; Hadad I; Thoma P; Metens T; da Costa AM; Mahmoudabady M; Egrise D; Blocklet D; Mazouz N; Naeije R; Heyndrickx G; McEntee K
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):646-53. PubMed ID: 19698851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell transplantation in heart failure: where do we stand in 2016?
    MacArthur JW; Goldstone AB; Cohen JE; Hiesinger W; Woo YJ
    Eur J Cardiothorac Surg; 2016 Sep; 50(3):396-9. PubMed ID: 27587719
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced cell therapy for ischemic heart disease.
    Bonaros N; Rauf R; Schachner T; Laufer G; Kocher A
    Transplantation; 2008 Nov; 86(9):1151-60. PubMed ID: 19005393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-guided myocardial cell therapy.
    Dick AJ; Lederman RJ
    Int J Cardiovasc Intervent; 2005; 7(4):165-70. PubMed ID: 16373261
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research progress of traditional Chinese medicine for stem cell therapy of ischemic heart disease].
    Wu H; Hu Y; Zhou Y; Chu Y
    Zhongguo Zhong Yao Za Zhi; 2009 Apr; 34(8):935-8. PubMed ID: 19639769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.